Literature DB >> 31286445

Coupling Fluorescence-Activated Cell Sorting and Targeted Analysis of Histone Modification Profiles in Primary Human Leukocytes.

Jeannie M Camarillo1, Suchitra Swaminathan2, Nebiyu A Abshiru1, Jacek W Sikora1, Paul M Thomas3, Neil L Kelleher4.   

Abstract

Histone posttranslational modifications (PTMs) are essential for regulating chromatin and maintaining gene expression throughout cell differentiation. Despite the deep level of understanding of immunophenotypic differentiation pathways in hematopoietic cells, few studies have investigated global levels of histone PTMs required for differentiation and maintenance of these distinct cell types. Here, we describe an approach to couple fluorescence-activated cell sorting (FACS) with targeted mass spectrometry to define global "epi-proteomic" signatures for primary leukocytes. FACS was used to sort closely and distantly related leukocytes from normal human peripheral blood for quantitation of histone PTMs with a multiple reaction monitoring LC-MS/MS method measuring histone PTMs on histones H3 and H4. We validate cell sorting directly into H2SO4 for immediate histone extraction to decrease time and number of steps after FACS to analyze histone PTMs. Relative histone PTM levels vary in T cells across healthy donors, and the majority of PTMs remain stable up to 2 days following initial blood draw. Large differences in the levels of histone PTMs are observed across the mature lymphoid and myeloid lineages, as well as between different types within the same lineage, though no differences are observed in closely related T cell subtypes. The results show a streamlined approach for quantifying global changes in histone PTMs in cell types separated by FACS that is poised for clinical deployment.

Entities:  

Keywords:  Fluorescence-activated cell sorting; Histones; Posttranslation modifications; Proteomics; Targeted LC-MS/MS

Mesh:

Substances:

Year:  2019        PMID: 31286445      PMCID: PMC6917871          DOI: 10.1007/s13361-019-02255-x

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  34 in total

1.  Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.

Authors:  Kate Poropatich; Joel Fontanarosa; Suchitra Swaminathan; Dave Dittmann; Siqi Chen; Sandeep Samant; Bin Zhang
Journal:  J Pathol       Date:  2017-10-06       Impact factor: 7.996

2.  Quantitative assessment of chromatin immunoprecipitation grade antibodies directed against histone modifications reveals patterns of co-occurring marks on histone protein molecules.

Authors:  Sally E Peach; Emily L Rudomin; Namrata D Udeshi; Steven A Carr; Jacob D Jaffe
Journal:  Mol Cell Proteomics       Date:  2012-03-21       Impact factor: 5.911

3.  Histone H3K27ac separates active from poised enhancers and predicts developmental state.

Authors:  Menno P Creyghton; Albert W Cheng; G Grant Welstead; Tristan Kooistra; Bryce W Carey; Eveline J Steine; Jacob Hanna; Michael A Lodato; Garrett M Frampton; Phillip A Sharp; Laurie A Boyer; Richard A Young; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

Review 4.  The role of chromatin during transcription.

Authors:  Bing Li; Michael Carey; Jerry L Workman
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

5.  Combinatorial modification of human histone H4 quantitated by two-dimensional liquid chromatography coupled with top down mass spectrometry.

Authors:  James J Pesavento; Courtney R Bullock; Richard D LeDuc; Craig A Mizzen; Neil L Kelleher
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

6.  Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies.

Authors:  J A Oyer; X Huang; Y Zheng; J Shim; T Ezponda; Z Carpenter; M Allegretta; C I Okot-Kotber; J P Patel; A Melnick; R L Levine; A Ferrando; A D Mackerell; N L Kelleher; J D Licht; R Popovic
Journal:  Leukemia       Date:  2013-07-04       Impact factor: 11.528

7.  The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia.

Authors:  Eytan M Stein; Guillermo Garcia-Manero; David A Rizzieri; Raoul Tibes; Jesus G Berdeja; Michael R Savona; Mojca Jongen-Lavrenic; Jessica K Altman; Blythe Thomson; Stephen J Blakemore; Scott R Daigle; Nigel J Waters; A Benjamin Suttle; Alicia Clawson; Roy Pollock; Andrei Krivtsov; Scott A Armstrong; Jorge DiMartino; Eric Hedrick; Bob Löwenberg; Martin S Tallman
Journal:  Blood       Date:  2018-05-03       Impact factor: 22.113

8.  EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.

Authors:  Wendy Béguelin; Relja Popovic; Matt Teater; Yanwen Jiang; Karen L Bunting; Monica Rosen; Hao Shen; Shao Ning Yang; Ling Wang; Teresa Ezponda; Eva Martinez-Garcia; Haikuo Zhang; Yupeng Zheng; Sharad K Verma; Michael T McCabe; Heidi M Ott; Glenn S Van Aller; Ryan G Kruger; Yan Liu; Charles F McHugh; David W Scott; Young Rock Chung; Neil Kelleher; Rita Shaknovich; Caretha L Creasy; Randy D Gascoyne; Kwok-Kin Wong; Leandro Cerchietti; Ross L Levine; Omar Abdel-Wahab; Jonathan D Licht; Olivier Elemento; Ari M Melnick
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

9.  Transcription and enhancer profiling in human monocyte subsets.

Authors:  Christian Schmidl; Kathrin Renner; Katrin Peter; Ruediger Eder; Timo Lassmann; Piotr J Balwierz; Masayoshi Itoh; Sayaka Nagao-Sato; Hideya Kawaji; Piero Carninci; Harukazu Suzuki; Yoshihide Hayashizaki; Reinhard Andreesen; David A Hume; Petra Hoffmann; Alistair R R Forrest; Marina P Kreutz; Matthias Edinger; Michael Rehli
Journal:  Blood       Date:  2014-03-26       Impact factor: 22.113

10.  An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.

Authors:  George P Souroullas; William R Jeck; Joel S Parker; Jeremy M Simon; Jie-Yu Liu; Joshiawa Paulk; Jessie Xiong; Kelly S Clark; Yuri Fedoriw; Jun Qi; Christin E Burd; James E Bradner; Norman E Sharpless
Journal:  Nat Med       Date:  2016-05-02       Impact factor: 53.440

View more
  5 in total

1.  SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.

Authors:  Wilfred Leung; Matt Teater; Ceyda Durmaz; Cem Meydan; Alexandra G Chivu; Amy Chadburn; Edward J Rice; Ashlesha Muley; Jeannie M Camarillo; Jaison Arivalagan; Ziyi Li; Christopher R Flowers; Neil L Kelleher; Charles G Danko; Marcin Imielinski; Sandeep S Dave; Scott A Armstrong; Christopher E Mason; Ari M Melnick
Journal:  Cancer Discov       Date:  2022-07-06       Impact factor: 38.272

2.  mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis.

Authors:  Elodie Villa; Umakant Sahu; Brendan P O'Hara; Eunus S Ali; Kathryn A Helmin; John M Asara; Peng Gao; Benjamin D Singer; Issam Ben-Sahra
Journal:  Mol Cell       Date:  2021-03-22       Impact factor: 17.970

3.  Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma.

Authors:  Shejuan An; Jeannie M Camarillo; Tina Yi-Ting Huang; Daphne Li; Juliette A Morris; Madeline A Zoltek; Jin Qi; Mandana Behbahani; Madhuri Kambhampati; Neil L Kelleher; Javad Nazarian; Paul M Thomas; Amanda M Saratsis
Journal:  J Exp Clin Cancer Res       Date:  2020-11-25

4.  Mitochondrial respiration controls the Prox1-Vegfr3 feedback loop during lymphatic endothelial cell fate specification and maintenance.

Authors:  Wanshu Ma; Hyea Jin Gil; Xiaolei Liu; Lauren P Diebold; Marc A Morgan; Michael J Oxendine-Burns; Peng Gao; Navdeep S Chandel; Guillermo Oliver
Journal:  Sci Adv       Date:  2021-04-30       Impact factor: 14.136

5.  The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing.

Authors:  Sara Parsa; Ana Ortega-Molina; Hsia-Yuan Ying; Man Jiang; Matt Teater; Jiahui Wang; Chunying Zhao; Ed Reznik; Joyce P Pasion; David Kuo; Prathibha Mohan; Shenqiu Wang; Jeannie M Camarillo; Paul M Thomas; Neeraj Jain; Javier Garcia-Bermudez; Byoung-Kyu Cho; Wayne Tam; Neil L Kelleher; Nicholas Socci; Ahmet Dogan; Elisa De Stanchina; Giovanni Ciriello; Michael R Green; Sheng Li; Kivanc Birsoy; Ari M Melnick; Hans-Guido Wendel
Journal:  Nat Cancer       Date:  2020-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.